Authors:
Ekert, H
Brewin, T
Boey, W
Davey, P
Tilden, D
Citation: H. Ekert et al., Cost-utility analysis of recombinant factor VIIa (NovoSeven((R))) in six children with long-standing inhibitors to factor VIII or IX, HAEMOPHILIA, 7(3), 2001, pp. 279-285